Month: August 2020

NEWTOWN, Pa., Aug. 31, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX) a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the election of James J. Marino, JD, MBA as Chairman of the Board of Directors. Mr. Marino brings more than three decades of experience advising numerous leading life science companies in connection with corporate transactions and strategic alliances.Mr. Marino has served as a Director of Onconova since July 2015, a Director of Celldex Therapeutics, Inc. since March 2017, and previously as a Director of Pharmacopeia, Inc. Mr. Marino served on the Board of Trustees of Wake Forest University and its renowned Medical Center, and previously served on the Board of Trustees of Robert Wood Johnson University Hospital. He is a co-founder...

Phase 2/3 COMET-ICE study will investigate the safety and efficacy of antibody treatment in preventing hospitalization due to COVID-19 Potential for initial study results to be available before the end of 2020, with early access to the antibody treatment as soon as the first half of 2021SAN FRANCISCO and LONDON, Aug. 31, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) announced that the first patient was dosed last week in a Phase 2/3 study with VIR-7831 (also known as GSK4182136), a fully human anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus-2) monoclonal antibody, for the early treatment of COVID-19 in patients who are at high risk of hospitalization.The aim of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial – Intent to Care Early) study, which...

NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Dennis Hruby, SIGA’s Chief Scientific Officer, has been named a recipient of the 2021 American Society for Microbiology (ASM) Award for Applied and Biotechnological Research. The award recognizes an outstanding scientist with distinguished research achievements in the development of products, processes and technologies that have advanced the microbial sciences.“It is an honor to receive this prestigious award, especially given the high quality of microbial research being conducted in academic and corporate laboratories around the world,” said Dr. Hruby. “The current COVID-19 pandemic underscores the importance of continued research...

TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Artificial Intelligence company, AnalytixInsight Inc. (“AnalytixInsight”, or the “Company”) (TSX-V: ALY; OTCQB: ATIXF), reports its financial results for the second quarter ended June 30, 2020.HighlightsThe Company’s CapitalCube AI-driven research distribution agreement with Refinitiv continued to witness strong readership during the quarter as users embrace the use of AI in fundamental financial analysis. The growth of content disseminated through Refinitiv’s Eikon platform was the strongest in its operating history.Initiated development of robo-based ETF and equity analysis to create and develop proprietary indices to be featured in a new version of index driven products in CapitalCube.Offered free access to CapitalCube financial analytics platform in support of investors and investment...

SAN CLEMENTE, CA, Aug. 31, 2020 (GLOBE NEWSWIRE) —  via NEWMEDIAWIRE ‒ Global WholeHealth Partners Corp. (OTC Pink: GWHP) today announced Goldman Small Cap Research has published an initial analyst report covering GWHP’s outlook.GWHP is an emerging rapid diagnostic point-of-care (PoC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. GWHP was awarded a CE Mark for its high quality, rapid anti-body test for COVID-19 and an EUA filing with the FDA is pending approval. This report carries a price target. To view the new research report, along with disclosures and disclaimers, or to download it in its entirety, please visit https://bit.ly/3lz68yr.About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research...

FORT WORTH, TX, Aug. 31, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ ADM Endeavors, Inc. (OTCQB: ADMQ) is pleased to announce that the Company will relocate its Arlington, Texas retail school uniform storefront location. The services provided by this location will reopen in the new 70,000 square-foot expansion facility currently in development by the Company. This move will save more than $10,000 per month.ADM Endeavors, Inc.’s CEO, Marc Johnson, said the Company will save more than $10,000 per month in fixed costs and eliminate the labor needed to maintain the retail location. Ninety percent of the revenue from this location came during the months of June, July, and August when the demand for school uniforms peaked. Currently, the uniform obligations have been met for the current academic school year.The services previously provided...

VANCOUVER, British Columbia, Aug. 31, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality for eCommerce, AR learning applications, AR-enhanced video conferencing and virtual events is pleased to announce that its recently launched  augmented reality solution for video ‘ScreenAR’ has generated over $100,000 in sales in its first month and is gaining great momentum. ‘ScreenAR’ has been seamlessly integrated into the InfernoAR platform and uses the company’s ARitize technology. With the integration of its augmented reality solutions into its video conferencing events platform InfernoAR, NexTech has created a unique suite of product offerings that helps companies drive their digital transformation. With the rapid rollout and adoption of ‘ScreenAR’...

LOS ANGELES, CA, Aug. 31, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 4:00 PM EST. Gerald Commissiong, President & CEO of Todos, will be presenting to a live virtual audience.For the real time presentation register here: https://ld500.ldmicro.com/.  In addition, a replay will be available on Todos’ website here.“We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world...

FDA sets PDUFA goal date of February 28, 2021Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patients BERKELEY HEIGHTS, N.J., Aug. 31, 2020 (GLOBE NEWSWIRE) — CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s submitted New Drug Application (NDA) for Defencath™, its product candidate to be used as a catheter lock solution in hemodialysis patients for the prevention of catheter related blood stream infections (CRBSI). The FDA had previously granted a rolling submission and review, which the Company...